The uTRACT registry: A single-arm, multicenter, prospective, and retrospective registry study to evaluate the real-world use of UGN-101 in participants with upper tract urothelial carcinoma (UTUC) in the United States.
Year: 2025
Type: article
Study design: Observational Study
Source: Journal of Clinical Oncology
Authors: Adam Feldman, Yair Lotan, Soloman Woldu, Mehrad Adibi, Marc Bjurlin, Eliza DeFroda, Rian J. Dickstein, Khurshid R. Ghani, David Hoenig, Joseph M. Jacob, Hristos Z. Kaimakliotis, Jennifer Linehan, Joshua J. Meeks, Katie S. Murray, Nirmish Singla, Karthik Tanneru, Hetal Pandya, Nikky Ugwuoke, Brent Burger, Michael J Louie, uTRACT Registry Study Group
Institutions: Massachusetts General Hospital, The University of Texas Southwestern Medical Center, The University of Texas MD Anderson Cancer Center, University of North Carolina at Chapel Hill, University of Missouri, University of Michigan, Northwell Health, SUNY Upstate Medical University, Indiana University School of Medicine, Northwestern University, NYU Langone Health, Johns Hopkins University, Johns Hopkins Medicine, Johns Hopkins Hospital, UroGen Pharma Ltd. (United States)
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: UroGen Pharma
OpenAlex ID: W4410816975